Cargando...
Target engagement imaging of PARP inhibitors in small-cell lung cancer
Insufficient chemotherapy response and rapid disease progression remain concerns for small-cell lung cancer (SCLC). Oncologists rely on serial CT scanning to guide treatment decisions, but this cannot assess in vivo target engagement of therapeutic agents. Biomarker assessments in biopsy material do...
Guardado en:
| Publicado en: | Nat Commun |
|---|---|
| Autores principales: | , , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Nature Publishing Group UK
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5766608/ https://ncbi.nlm.nih.gov/pubmed/29330466 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41467-017-02096-w |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|